Your doctor says "everything looks fine" — but fine compared to what? This free tool takes the numbers from your lab report and tells you what they actually mean, flagging values that are inside the standard reference range but outside the optimal range for a 40-to-60-year-old man trying to stay healthy for another 30 years. It covers eight panels: lipids (TC, LDL, HDL, triglycerides, ApoB, Lp(a)), blood sugar (fasting glucose, A1C, fasting insulin, HOMA-IR), hormones (testosterone, free T, SHBG, estradiol), prostate (PSA), kidney, liver, inflammation and nutrients, and a full CBC.
Pull out your most recent CBC plus comprehensive metabolic panel plus lipid panel and enter whatever numbers you have. Any field left blank is skipped — you don't need every marker for the tool to be useful. The classification logic is built on 2026 ACC/AHA lipid guidelines, AACE endocrinology thresholds, and the latest published optimal ranges from preventive medicine literature (not LabCorp/Quest reference ranges, which are calibrated to "not sick" rather than "optimal"). The Smart Analysis panel ranks your flagged markers by priority and tells you which one to discuss with your doctor first.
The lipid panel is the most important section for a 40-60 year old man because cardiovascular disease is still the #1 killer in this age bracket. Enter what you have: Total Cholesterol, LDL, HDL, Triglycerides from any standard panel, plus ApoB and Lp(a) if your doctor ran them (most don't by default — ask at your next visit). LDL is the traditional target, but ApoB is the better single number because it counts every atherogenic particle, not just LDL cholesterol mass — two men with identical LDL can have very different ApoB depending on particle size and count. Lp(a) is a once-in-a-lifetime test: it's genetic, it doesn't change with diet or exercise, and about 20% of the population has an elevated level that triples their CVD risk. If you've never been tested, get it once. The decoder flags Lp(a) ≥30 mg/dL as worth a cardiology conversation regardless of your other numbers. HDL gets its own separate evaluation — below 40 is a risk factor on its own, and above 60 is genuinely protective.
Enter fasting glucose (most recent morning lab) and A1C (average glucose over the last 3 months) if you have them. A1C is the better long-term indicator but fasting glucose catches impaired fasting glycemia that A1C can miss. The optimal range is tighter than the "pre-diabetes" cutoff most labs use — the decoder uses the ADA's standard thresholds — fasting glucose ≥100 and A1C ≥5.7 flag as prediabetes — and pairs them with fasting insulin and HOMA-IR, which move years earlier than either. If you also have fasting insulin (rarely ordered but increasingly common in preventive medicine), the decoder computes HOMA-IR automatically — this is a sensitive insulin resistance measure that catches problems 5-10 years before fasting glucose moves. HOMA-IR above 2.0 is the earliest warning that you're sliding toward type 2 diabetes, and it responds to weight loss and resistance training faster than any other marker. If you're serious about metabolic health, add fasting insulin to your next blood draw.
Testosterone is the headline, but the numbers you should actually care about are total T and free T together, plus SHBG (sex hormone binding globulin). Total T measures all testosterone in your blood, but most of it is bound to SHBG and biologically inactive. Free T is the fraction actually doing work. A 55-year-old with total T of 550 and high SHBG can have free T in the clinically low range, and will feel it. The decoder evaluates both. Optimal total T for a man 40-60 is 500-900 ng/dL by the Endocrine Society (Travison et al. 2017) — the decoder flags total T below 264 ng/dL as low (the Endocrine Society threshold), and because symptoms often appear before that, it also evaluates free T and SHBG, which catch low active testosterone that a 'normal' total T can hide. Estradiol matters because men need some estrogen — around 20-40 pg/mL — for bone density, libido, and mood. Too low (usually from aromatase inhibitors or excessive zinc supplementation) is as bad as too high. If you're on TRT, estradiol should be monitored alongside testosterone.
Prostate-specific antigen is a screening marker, not a diagnostic. The traditional cutoff is 4.0 ng/mL, but age-adjusted ranges are more useful: optimal for a man 40-49 is under 2.5, for 50-59 under 3.5, for 60-69 under 4.5. The decoder uses age-adjusted thresholds. A single elevated PSA is not cancer — it can be from a recent bike ride, sex within 48 hours of the draw, an enlarged prostate (BPH), or prostatitis. What matters more than any single reading is PSA velocity: how fast it's rising year over year. A stable PSA of 3.2 is far less concerning than one that jumped from 1.8 to 3.2 in 12 months. If you haven't had a PSA drawn, the USPSTF recommends discussing with your doctor starting at age 55 (earlier if Black or with family history of prostate cancer). Bring any elevated reading to your doctor before panicking — most are false alarms, but velocity matters.
Kidney function quietly declines with age and most men don't know they're in stage 2 or 3 chronic kidney disease until it's caught on a routine panel. The headline numbers are creatinine (waste product your kidneys filter) and eGFR (estimated glomerular filtration rate, computed from creatinine and age). Normal eGFR is 90+; 60-89 is stage 2 mild reduction, 30-59 is stage 3 (where symptoms and decisions start), below 30 is serious. The decoder flags anything below 75 as worth watching and below 60 as worth a nephrology conversation. BUN (blood urea nitrogen) tracks alongside creatinine but is more influenced by protein intake, dehydration, and recent meals — interpret it as a secondary signal, not a primary one. The most common causes of declining kidney function in men 40-60 are poorly controlled blood pressure, diabetes, heavy NSAID use (ibuprofen every day for years), and dehydration. Flag this panel early — kidney damage is mostly irreversible.
The liver panel is where non-alcoholic fatty liver disease (NAFLD / MASLD) gets caught, and an estimated 25-30% of middle-aged American men have it without knowing. The key markers are ALT (most specific to liver), AST (also in heart/muscle), and GGT (sensitive to alcohol and biliary issues). Standard lab reference ranges are lenient — the decoder flags ALT above 30 for men as borderline (not the 40-50 most labs use) because elevated ALT in that range is the earliest sign of fatty liver. The AST/ALT ratio matters too: ratio above 2 suggests alcoholic hepatitis, ratio below 1 suggests NAFLD. GGT elevation without ALT elevation is often alcohol use even when the patient denies it. If you're drinking more than 7 drinks per week and your GGT is high, the two are almost certainly related. If your lab also reports bilirubin, an isolated mild elevation is usually benign Gilbert's syndrome.
This panel catches the "inflammation and nutrient deficiency" story that regular panels miss. hs-CRP (high-sensitivity C-reactive protein) is a general inflammation marker — below 1.0 is optimal, 1-3 is moderate, above 3 is high and associated with CVD and metabolic disease. If your hs-CRP is persistently above 2, something is driving systemic inflammation (visceral fat, gum disease, chronic sleep deprivation, autoimmune conditions). Homocysteine is driven by B-vitamin status — elevated homocysteine (above 10) is a CVD and dementia risk factor that's usually fixable with B12 + folate + B6. Vitamin D below 30 ng/mL is insufficient and below 20 is deficient; a surprising fraction of men in northern US states are chronically low in winter. B12 below 400 can cause fatigue, brain fog, and neuropathy well before the "clinical deficiency" cutoff of 200. Ferritin tracks iron stores — low ferritin (below 50 in men) suggests GI blood loss worth investigating, while high ferritin (above 300) can be hemochromatosis or inflammation.
CBC is the one panel everyone gets and almost nobody reads. The markers that matter most in a 40-60 year old man: hemoglobin and hematocrit (low = anemia or blood loss; unexpectedly high = dehydration or polycythemia), RDW (red cell distribution width — elevated RDW is an underappreciated marker of all-cause mortality risk and usually reflects mixed deficiencies), white blood cell count (persistently high suggests chronic infection or inflammation; low can indicate immunosuppression or nutritional issues), and platelet count (low platelets matter for bleeding risk; high platelets can indicate inflammation or a bone marrow issue). The decoder flags borderline values that standard labs ignore. Isolated borderline CBC values are usually not urgent, but patterns (low hemoglobin + high RDW + low ferritin) tell a coherent story that a single marker can't. Bring any flagged CBC value to your doctor, especially if it's new compared to prior panels.
This decoder is an educational screening tool, not a diagnostic system. The classification thresholds are based on 2026 ACC/AHA Dyslipidemia Guidelines, the American Diabetes Association, the Endocrine Society (Travison et al. 2017), NIH/NIDDK, and published preventive medicine literature — but they are general-population thresholds that do not account for your full medical history, current medications, family history, symptoms, recent illnesses, intense exercise within 48 hours of the draw, or lab-specific reference range variation. A single abnormal value is rarely meaningful — trends across multiple draws are what matter. Do not make medication changes, stop prescribed drugs, start supplements, or panic based on this tool. Its purpose is to help you walk into your next doctor's appointment with a clear list of markers worth discussing. For actionable decisions, bring the raw lab report and this tool's output to your primary care physician or a preventive medicine specialist. If any marker is flagged critical (red), schedule an appointment within 1-2 weeks.